LP31713-8

Ziprasidone

Active

Description

Ziprasidone, a benzisothiazoylpiperazine derivative, has combined dopamine and serotonin receptor antagonist activity, and is structurally related to tiospirone. It is an atypical antipsychotic agent used to treat the symptoms of schizophrenia. It is also used to treat episodes of mania, or mixed episodes (symptoms of mania and depression that happen together) in patients with bipolar disorder. Ziprasidone is not approved by the Food and Drug Administration (FDA) for the treatment of behavior problems in older adults with dementia as taking antipsychotics such as ziprasidone increases the risk of stroke or death during treatment for those patients. Source: Regenstrief LOINC, MedlinePlus: a699062

Basic Part Properties

Part Name

Ziprasidone

Part Display Name

Ziprasidone

Part Type

Component (Describes the core component or analyte measured)

Created On

2003-04-23

Construct for LOINC Short Name

Ziprasidone

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP31713-8

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP31713-8

Language Variants Get Info

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.